203 related articles for article (PubMed ID: 34021242)
21. WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma.
Zhukova N; Ramaswamy V; Remke M; Martin DC; Castelo-Branco P; Zhang CH; Fraser M; Tse K; Poon R; Shih DJ; Baskin B; Ray PN; Bouffet E; Dirks P; von Bueren AO; Pfaff E; Korshunov A; Jones DT; Northcott PA; Kool M; Pugh TJ; Pomeroy SL; Cho YJ; Pietsch T; Gessi M; Rutkowski S; Bognár L; Cho BK; Eberhart CG; Conter CF; Fouladi M; French PJ; Grajkowska WA; Gupta N; Hauser P; Jabado N; Vasiljevic A; Jung S; Kim SK; Klekner A; Kumabe T; Lach B; Leonard JR; Liau LM; Massimi L; Pollack IF; Ra YS; Rubin JB; Van Meir EG; Wang KC; Weiss WA; Zitterbart K; Bristow RG; Alman B; Hawkins CE; Malkin D; Clifford SC; Pfister SM; Taylor MD; Tabori U
Acta Neuropathol Commun; 2014 Dec; 2():174. PubMed ID: 25539912
[TBL] [Abstract][Full Text] [Related]
22. Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth.
Yao M; Ventura PB; Jiang Y; Rodriguez FJ; Wang L; Perry JSA; Yang Y; Wahl K; Crittenden RB; Bennett ML; Qi L; Gong CC; Li XN; Barres BA; Bender TP; Ravichandran KS; Janes KA; Eberhart CG; Zong H
Cell; 2020 Feb; 180(3):502-520.e19. PubMed ID: 31983537
[TBL] [Abstract][Full Text] [Related]
23.
Tao R; Murad N; Xu Z; Zhang P; Okonechnikov K; Kool M; Rivero-Hinojosa S; Lazarski C; Zheng P; Liu Y; Eberhart CG; Rood BR; Packer R; Pei Y
Cancer Res; 2019 Apr; 79(8):1967-1980. PubMed ID: 30862721
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional repressor REST drives lineage stage-specific chromatin compaction at
Dobson THW; Tao RH; Swaminathan J; Maegawa S; Shaik S; Bravo-Alegria J; Sharma A; Kennis B; Yang Y; Callegari K; Haltom AR; Taylor P; Kogiso M; Qi L; Khatua S; Goldman S; Lulla RR; Fangusaro J; MacDonald TJ; Li XN; Hawkins C; Rajaram V; Gopalakrishnan V
Sci Signal; 2019 Jan; 12(565):. PubMed ID: 30670636
[TBL] [Abstract][Full Text] [Related]
25. Medulloblastoma tumorigenesis diverges from cerebellar granule cell differentiation in patched heterozygous mice.
Kim JY; Nelson AL; Algon SA; Graves O; Sturla LM; Goumnerova LC; Rowitch DH; Segal RA; Pomeroy SL
Dev Biol; 2003 Nov; 263(1):50-66. PubMed ID: 14568546
[TBL] [Abstract][Full Text] [Related]
26. Single-cell spatial transcriptomic analysis reveals common and divergent features of developing postnatal granule cerebellar cells and medulloblastoma.
Luo W; Lin GN; Song W; Zhang Y; Lai H; Zhang M; Miao J; Cheng X; Wang Y; Li W; Wei W; Gao WQ; Yang R; Wang J
BMC Biol; 2021 Jul; 19(1):135. PubMed ID: 34210306
[TBL] [Abstract][Full Text] [Related]
27. Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.
Forget A; Martignetti L; Puget S; Calzone L; Brabetz S; Picard D; Montagud A; Liva S; Sta A; Dingli F; Arras G; Rivera J; Loew D; Besnard A; Lacombe J; Pagès M; Varlet P; Dufour C; Yu H; Mercier AL; Indersie E; Chivet A; Leboucher S; Sieber L; Beccaria K; Gombert M; Meyer FD; Qin N; Bartl J; Chavez L; Okonechnikov K; Sharma T; Thatikonda V; Bourdeaut F; Pouponnot C; Ramaswamy V; Korshunov A; Borkhardt A; Reifenberger G; Poullet P; Taylor MD; Kool M; Pfister SM; Kawauchi D; Barillot E; Remke M; Ayrault O
Cancer Cell; 2018 Sep; 34(3):379-395.e7. PubMed ID: 30205043
[TBL] [Abstract][Full Text] [Related]
28. Subtypes of medulloblastoma have distinct developmental origins.
Gibson P; Tong Y; Robinson G; Thompson MC; Currle DS; Eden C; Kranenburg TA; Hogg T; Poppleton H; Martin J; Finkelstein D; Pounds S; Weiss A; Patay Z; Scoggins M; Ogg R; Pei Y; Yang ZJ; Brun S; Lee Y; Zindy F; Lindsey JC; Taketo MM; Boop FA; Sanford RA; Gajjar A; Clifford SC; Roussel MF; McKinnon PJ; Gutmann DH; Ellison DW; Wechsler-Reya R; Gilbertson RJ
Nature; 2010 Dec; 468(7327):1095-9. PubMed ID: 21150899
[TBL] [Abstract][Full Text] [Related]
29. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma.
Schüller U; Heine VM; Mao J; Kho AT; Dillon AK; Han YG; Huillard E; Sun T; Ligon AH; Qian Y; Ma Q; Alvarez-Buylla A; McMahon AP; Rowitch DH; Ligon KL
Cancer Cell; 2008 Aug; 14(2):123-34. PubMed ID: 18691547
[TBL] [Abstract][Full Text] [Related]
30. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.
Cho YJ; Tsherniak A; Tamayo P; Santagata S; Ligon A; Greulich H; Berhoukim R; Amani V; Goumnerova L; Eberhart CG; Lau CC; Olson JM; Gilbertson RJ; Gajjar A; Delattre O; Kool M; Ligon K; Meyerson M; Mesirov JP; Pomeroy SL
J Clin Oncol; 2011 Apr; 29(11):1424-30. PubMed ID: 21098324
[TBL] [Abstract][Full Text] [Related]
31. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
[TBL] [Abstract][Full Text] [Related]
32. Medulloblastoma comprises four distinct molecular variants.
Northcott PA; Korshunov A; Witt H; Hielscher T; Eberhart CG; Mack S; Bouffet E; Clifford SC; Hawkins CE; French P; Rutka JT; Pfister S; Taylor MD
J Clin Oncol; 2011 Apr; 29(11):1408-14. PubMed ID: 20823417
[TBL] [Abstract][Full Text] [Related]
33. Developmental origins and oncogenic pathways in malignant brain tumors.
Lu QR; Qian L; Zhou X
Wiley Interdiscip Rev Dev Biol; 2019 Jul; 8(4):e342. PubMed ID: 30945456
[TBL] [Abstract][Full Text] [Related]
34. Spatial heterogeneity in medulloblastoma.
Morrissy AS; Cavalli FMG; Remke M; Ramaswamy V; Shih DJH; Holgado BL; Farooq H; Donovan LK; Garzia L; Agnihotri S; Kiehna EN; Mercier E; Mayoh C; Papillon-Cavanagh S; Nikbakht H; Gayden T; Torchia J; Picard D; Merino DM; Vladoiu M; Luu B; Wu X; Daniels C; Horswell S; Thompson YY; Hovestadt V; Northcott PA; Jones DTW; Peacock J; Wang X; Mack SC; Reimand J; Albrecht S; Fontebasso AM; Thiessen N; Li Y; Schein JE; Lee D; Carlsen R; Mayo M; Tse K; Tam A; Dhalla N; Ally A; Chuah E; Cheng Y; Plettner P; Li HI; Corbett RD; Wong T; Long W; Loukides J; Buczkowicz P; Hawkins CE; Tabori U; Rood BR; Myseros JS; Packer RJ; Korshunov A; Lichter P; Kool M; Pfister SM; Schüller U; Dirks P; Huang A; Bouffet E; Rutka JT; Bader GD; Swanton C; Ma Y; Moore RA; Mungall AJ; Majewski J; Jones SJM; Das S; Malkin D; Jabado N; Marra MA; Taylor MD
Nat Genet; 2017 May; 49(5):780-788. PubMed ID: 28394352
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation.
Fernandez-L A; Squatrito M; Northcott P; Awan A; Holland EC; Taylor MD; Nahlé Z; Kenney AM
Oncogene; 2012 Apr; 31(15):1923-37. PubMed ID: 21874045
[TBL] [Abstract][Full Text] [Related]
36. Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma.
Ward RJ; Lee L; Graham K; Satkunendran T; Yoshikawa K; Ling E; Harper L; Austin R; Nieuwenhuis E; Clarke ID; Hui CC; Dirks PB
Cancer Res; 2009 Jun; 69(11):4682-90. PubMed ID: 19487286
[TBL] [Abstract][Full Text] [Related]
37. MiR-34a deficiency accelerates medulloblastoma formation in vivo.
Thor T; Künkele A; Pajtler KW; Wefers AK; Stephan H; Mestdagh P; Heukamp L; Hartmann W; Vandesompele J; Sadowski N; Becker L; Garrett L; Hölter SM; Horsch M; Calzada-Wack J; Klein-Rodewald T; Racz I; Zimmer A; Beckers J; Neff F; Klopstock T; De Antonellis P; Zollo M; Wurst W; Fuchs H; Gailus-Durner V; Schüller U; de Angelis MH; Eggert A; Schramm A; Schulte JH
Int J Cancer; 2015 May; 136(10):2293-303. PubMed ID: 25348795
[TBL] [Abstract][Full Text] [Related]
38. ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation.
Lang PY; Nanjangud GJ; Sokolsky-Papkov M; Shaw C; Hwang D; Parker JS; Kabanov AV; Gershon TR
Development; 2016 Nov; 143(21):4038-4052. PubMed ID: 27803059
[TBL] [Abstract][Full Text] [Related]
39. ASC deficiency suppresses proliferation and prevents medulloblastoma incidence.
Knight ER; Patel EY; Flowers CA; Crowther AJ; Ting JP; Miller CR; Gershon TR; Deshmukh M
Oncogene; 2015 Jan; 34(3):394-402. PubMed ID: 24469054
[TBL] [Abstract][Full Text] [Related]
40. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.
Zhukova N; Ramaswamy V; Remke M; Pfaff E; Shih DJ; Martin DC; Castelo-Branco P; Baskin B; Ray PN; Bouffet E; von Bueren AO; Jones DT; Northcott PA; Kool M; Sturm D; Pugh TJ; Pomeroy SL; Cho YJ; Pietsch T; Gessi M; Rutkowski S; Bognar L; Klekner A; Cho BK; Kim SK; Wang KC; Eberhart CG; Fevre-Montange M; Fouladi M; French PJ; Kros M; Grajkowska WA; Gupta N; Weiss WA; Hauser P; Jabado N; Jouvet A; Jung S; Kumabe T; Lach B; Leonard JR; Rubin JB; Liau LM; Massimi L; Pollack IF; Shin Ra Y; Van Meir EG; Zitterbart K; Schüller U; Hill RM; Lindsey JC; Schwalbe EC; Bailey S; Ellison DW; Hawkins C; Malkin D; Clifford SC; Korshunov A; Pfister S; Taylor MD; Tabori U
J Clin Oncol; 2013 Aug; 31(23):2927-35. PubMed ID: 23835706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
